RHOC and endometrial carcinoma: Furthermore, as a lncRNA, TDRG1 enhanced tumorigenicity by inhibiting the miR-93/RhoC pathway in epithelial ovarian carcinoma [11] and promoted endometrial carcinoma cell development and invasion by positively targeting VEGF-A in endometrial carcinoma [12].